Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exacerbations and Their Outcomes in Egyptian Patients (EXACOS EG Population): Understanding the Burden of Severe Exacerbations of COPD and the Association Between Frequency of Severe Exacerbations and Clinical and Health-care Utilization Outcomes in Less Well-resourced Countries: Sample of Egyptian Patients.

NCT06983340 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT06983340
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06983340 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exacerbations and Their Outcomes in Egyptian Patients (EXACOS EG Population): Understanding the Burden of Severe Exacerbations of COPD and the Association Between Frequency of Severe Exacerbations and Clinical and Health-care Utilization Outcomes in Less Well-resourced Countries: Sample of Egyptian Patients.
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Withdrawn
Start date
August 30, 2025
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease